Jung-Yeon Choi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jung-Yeon Choi has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
- Kwang-Il Kim
Seoul National University Bundang Hospital
28 shared publications - Sun-Wook Kim
Department of Hospital Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
7 shared publications Cheol-Ho Kim
Departmentof Internal Medicine, Seoul National University Bundang Hospital, Seongnam (J.-Y.C., C.-H.K., K.-I.K.).
6 shared publications- Min-Gu Kang
Department of Internal Medicine Chonnam National University Bitgoeul Hospital Gwangju South Korea
6 shared publications - Cheol-Ho Kim
Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
5 shared publications - Hae-Young Lee
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
4 shared publications
Latest Publications
- Open Access
- 19 November 2026
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 5 (11) , e0001838
Multimodal deep learning approach for frailty classification using electrocardiogram and chest X-ray imaging
Frailty is a critical age-related syndrome associated with increased risks of disability, hospitalization, and mortality. While Comprehensive Geriatric Assessment (CGA) is the standard for evaluation, it is often subjective, time-consuming, and resource-intensive. To address these limitations, this study developed and validated a multimodal deep learning framework that integrates chest X-rays (CXR) and electrocardiograms (ECG) to provide an objective and rapid tool for frailty classification. We retrospectively analyzed data from 2,830 older adults who underwent CGA between 2007 and 2024, partitioned chronologically into training, validation, and test sets. Frailty was defined using a Multidimensional Frailty Score (MFS) > 5. Three deep learning models were trained and evaluated: a CXR-only model (EVA-X vision transformer), an ECG-only model (DenseNet-121), and a multimodal model combining both inputs. The multimodal model outperformed the single-modality models and four non-imaging clinical baseline models incorporating age, sex, comorbidity index, or routine laboratory variables, achieving the highest area under the receiver operating characteristic curve (AUROC) of 0.778 and area under the precision-recall curve (AUPRC) of 0.726. For continuous MFS estimation, the multimodal model achieved the highest Pearson correlation (r = 0.610) and the lowest mean absolute error (MAE = 1.68) among the evaluated models. Gradient-weighted Class Activation Mapping (Grad-CAM) was used to qualitatively explore the image regions that influenced model predictions. This multimodal AI framework demonstrates modest classification performance and feasibility for frailty screening. By leveraging routinely collected clinical images, this framework may serve as a practical screening adjunct to identify older adults who may benefit from formal CGA. Further studies are needed to determine its clinical utility when applied preoperatively for the stratification of postoperative risk.
- 19 November 2026
- Published by Public Library of Science (PLoS) in PLOS Digital Health
- Vol. 5 (11) , e0001838
Open AccessMultimodal deep learning approach for frailty classification using electrocardiogram and chest X-ray imaging
Frailty is a critical age-related syndrome associated with increased risks of disability, hospitalization, and mortality. While Comprehensive Geriatric Assessment (CGA) is the standard for evaluation, it is often subjective, time-consuming, and resource-intensive. To address these limitations, this study developed and validated a multimodal deep learning framework that integrates chest X-rays (CXR) and electrocardiograms (ECG) to provide an objective and rapid tool for frailty classification. We retrospectively analyzed data from 2,830 older adults who underwent CGA between 2007 and 2024, partitioned chronologically into training, validation, and test sets. Frailty was defined using a Multidimensional Frailty Score (MFS) > 5. Three deep learning models were trained and evaluated: a CXR-only model (EVA-X vision transformer), an ECG-only model (DenseNet-121), and a multimodal model combining both inputs. The multimodal model outperformed the single-modality models and four non-imaging clinical baseline models incorporating age, sex, comorbidity index, or routine laboratory variables, achieving the highest area under the receiver operating characteristic curve (AUROC) of 0.778 and area under the precision-recall curve (AUPRC) of 0.726. For continuous MFS estimation, the multimodal model achieved the highest Pearson correlation (r = 0.610) and the lowest mean absolute error (MAE = 1.68) among the evaluated models. Gradient-weighted Class Activation Mapping (Grad-CAM) was used to qualitatively explore the image regions that influenced model predictions. This multimodal AI framework demonstrates modest classification performance and feasibility for frailty screening. By leveraging routinely collected clinical images, this framework may serve as a practical screening adjunct to identify older adults who may benefit from formal CGA. Further studies are needed to determine its clinical utility when applied preoperatively for the stratification of postoperative risk.
- Open Access
- 7 April 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26
Prognostic utility of sarcopenia and frailty on postoperative complication and mortality in older intermediate risk cancer surgery
Conditions such as sarcopenia and frailty, which become more prevalent with age, significantly influence the outcomes of older patients with cancer undergo
- 7 April 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26
Open AccessPrognostic utility of sarcopenia and frailty on postoperative complication and mortality in older intermediate risk cancer surgery
Conditions such as sarcopenia and frailty, which become more prevalent with age, significantly influence the outcomes of older patients with cancer undergo
- Open Access
- 6 March 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Functional impairment as predictors of renal outcomes and mortality in elderly patients: a retrospective cohort study
Functional impairments in elderly patients with chronic kidney disease may affect prognosis. This study evaluated the associations between activities of daily living (ADL), instrumental activities of daily living (IADL), renal replacement therapy (RRT), and mortality. We retrospectively analyzed 6,087 adults aged ≥65 years (2,737 men and 3,350 women) who underwent geriatric assessment at Seoul National University Bundang Hospital from 2016 to 2020. All had an estimated glomerular filtration rate (eGFR) >15 mL/min/1.73 m2 and were followed for more than 3 months. ADL and IADL were measured using the Barthel and Lawton-Brody Index, and analyses were stratified by sex due to differences in IADL scoring criteria. Participants (mean age, 78.7 ± 6.0 years; eGFR, 75.8 ± 19.4 mL/min/1.73 m2) were followed for a median of 42 months; 2,108 (34.6%) died and 103 (1.7%) initiated RRT. Impaired ADL and IADL were significantly associated with increased mortality in both sexes. In men, IADL impairment (<5) predicted RRT, whereas ADL (<100) showed a weaker association (p = 0.05). In women, neither ADL (<100) nor IADL (<8) significantly predicted RRT. Functional impairments independently predicted mortality in both sexes and were associated with a higher risk of RRT in men, particularly among younger individuals or those with preserved renal function. ADL and IADL assessments may provide practical indicators for identifying high-risk elderly patients with early-stage kidney disease.
- 6 March 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
Open AccessFunctional impairment as predictors of renal outcomes and mortality in elderly patients: a retrospective cohort study
Functional impairments in elderly patients with chronic kidney disease may affect prognosis. This study evaluated the associations between activities of daily living (ADL), instrumental activities of daily living (IADL), renal replacement therapy (RRT), and mortality. We retrospectively analyzed 6,087 adults aged ≥65 years (2,737 men and 3,350 women) who underwent geriatric assessment at Seoul National University Bundang Hospital from 2016 to 2020. All had an estimated glomerular filtration rate (eGFR) >15 mL/min/1.73 m2 and were followed for more than 3 months. ADL and IADL were measured using the Barthel and Lawton-Brody Index, and analyses were stratified by sex due to differences in IADL scoring criteria. Participants (mean age, 78.7 ± 6.0 years; eGFR, 75.8 ± 19.4 mL/min/1.73 m2) were followed for a median of 42 months; 2,108 (34.6%) died and 103 (1.7%) initiated RRT. Impaired ADL and IADL were significantly associated with increased mortality in both sexes. In men, IADL impairment (<5) predicted RRT, whereas ADL (<100) showed a weaker association (p = 0.05). In women, neither ADL (<100) nor IADL (<8) significantly predicted RRT. Functional impairments independently predicted mortality in both sexes and were associated with a higher risk of RRT in men, particularly among younger individuals or those with preserved renal function. ADL and IADL assessments may provide practical indicators for identifying high-risk elderly patients with early-stage kidney disease.
- Open Access
- 31 October 2025
- Published by Korean Society of Cardiovascular Disease Prevention in Cardiovascular Prevention and Pharmacotherapy
- Vol. 7 (4) , 135-140
Managing hypertension, diabetes, and dyslipidemia in frail older adults
As the population ages, the prevalence of chronic conditions, such as hypertension, type 2 diabetes, and dyslipidemia, is rapidly increasing, particularly among frail older adults. These conditions share common pathophysiological mechanisms and substantially contribute to the development of atherosclerotic cardiovascular disease. Effective management is essential for reducing cardiovascular risk; however, older adults present unique challenges, including multimorbidity, polypharmacy, cognitive decline, and functional impairment. Frailty further complicates clinical decision-making and necessitates individualized treatment strategies. This review examines current evidence and clinical guidelines for managing hypertension, diabetes, and dyslipidemia in older adults, with a focus on frailty status. It highlights the importance of assessing functional capacity and life expectancy and prioritizing treatments with favorable risk–benefit profiles. Specific recommendations are discussed according to frailty status, including when to initiate or deintensify therapy. Ultimately, a person-centered, geriatric-informed approach is critical to optimize outcomes and preserve quality of life in this vulnerable population.
- 31 October 2025
- Published by Korean Society of Cardiovascular Disease Prevention in Cardiovascular Prevention and Pharmacotherapy
- Vol. 7 (4) , 135-140
Open AccessManaging hypertension, diabetes, and dyslipidemia in frail older adults
As the population ages, the prevalence of chronic conditions, such as hypertension, type 2 diabetes, and dyslipidemia, is rapidly increasing, particularly among frail older adults. These conditions share common pathophysiological mechanisms and substantially contribute to the development of atherosclerotic cardiovascular disease. Effective management is essential for reducing cardiovascular risk; however, older adults present unique challenges, including multimorbidity, polypharmacy, cognitive decline, and functional impairment. Frailty further complicates clinical decision-making and necessitates individualized treatment strategies. This review examines current evidence and clinical guidelines for managing hypertension, diabetes, and dyslipidemia in older adults, with a focus on frailty status. It highlights the importance of assessing functional capacity and life expectancy and prioritizing treatments with favorable risk–benefit profiles. Specific recommendations are discussed according to frailty status, including when to initiate or deintensify therapy. Ultimately, a person-centered, geriatric-informed approach is critical to optimize outcomes and preserve quality of life in this vulnerable population.
- Open Access
- 1 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Multiple domain resilience components and frailty, postoperative complications, and one year quality of life deterioration after pancreatectomy in older patients
The number of older adults is growing rapidly worldwide, and many surgical diseases are prevalent in this population. Resilience, the ability to adapt positively to adversity, remains a multisystemic process with no standardized objective measurement methods. The aim of this study was to identify the association between resilience components and frailty, postoperative complications, and quality of life changes after pancreatectomy in older patients. This study evaluated older patients (aged ≥ 65) scheduled for pancreatectomy between August 2020 and December 2023. Patients who underwent a Comprehensive Geriatric Assessment and signed informed consent were included. Frailty was determined by multidimensional frailty score more than 5. Neurohumoral resilience was measured using the ACTH stimulation test, cardiovascular autonomic function using orthostatic blood pressure measurement, and cognitive-motor function using dual-task gait tests. The primary outcome was postoperative complications, and the secondary outcome was the deterioration in quality of life one year after pancreatectomy. A total of 57 patients were included in the analysis. Among them, 17 (29.8%) were classified as frail, 10 patients (17.5%) experienced postoperative complications, and 12 patients (24.5%) had worsened quality of life after one year. Low blood pressure and slow usual gait speed was associated with frailty. Diminished cortisol responsiveness correlated with frailty and postoperative complications. Quality of life deterioration was associated with differences between dual-task (serial 7) gait speed and fast gait speed. This study highlights the potential association between multidomain resilience components, frailty, and clinical outcomes in older patients undergoing pancreatectomy. Future research should focus on developing robust, objective, and reliable resilience metrics for clinical use.
- 1 April 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-7
Open AccessMultiple domain resilience components and frailty, postoperative complications, and one year quality of life deterioration after pancreatectomy in older patients
The number of older adults is growing rapidly worldwide, and many surgical diseases are prevalent in this population. Resilience, the ability to adapt positively to adversity, remains a multisystemic process with no standardized objective measurement methods. The aim of this study was to identify the association between resilience components and frailty, postoperative complications, and quality of life changes after pancreatectomy in older patients. This study evaluated older patients (aged ≥ 65) scheduled for pancreatectomy between August 2020 and December 2023. Patients who underwent a Comprehensive Geriatric Assessment and signed informed consent were included. Frailty was determined by multidimensional frailty score more than 5. Neurohumoral resilience was measured using the ACTH stimulation test, cardiovascular autonomic function using orthostatic blood pressure measurement, and cognitive-motor function using dual-task gait tests. The primary outcome was postoperative complications, and the secondary outcome was the deterioration in quality of life one year after pancreatectomy. A total of 57 patients were included in the analysis. Among them, 17 (29.8%) were classified as frail, 10 patients (17.5%) experienced postoperative complications, and 12 patients (24.5%) had worsened quality of life after one year. Low blood pressure and slow usual gait speed was associated with frailty. Diminished cortisol responsiveness correlated with frailty and postoperative complications. Quality of life deterioration was associated with differences between dual-task (serial 7) gait speed and fast gait speed. This study highlights the potential association between multidomain resilience components, frailty, and clinical outcomes in older patients undergoing pancreatectomy. Future research should focus on developing robust, objective, and reliable resilience metrics for clinical use.
- Open Access
- 16 January 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e57298
Development and Validation of a Machine Learning Method Using Vocal Biomarkers for Identifying Frailty in Community-Dwelling Older Adults: Cross-Sectional Study
Background: The two most commonly used methods to identify frailty are the frailty phenotype and the frailty index. However, both methods have limitations in clinical application. In addition, methods for measuring frailty have not yet been standardized. Objective: We aimed to develop and validate a classification model for predicting frailty status using vocal biomarkers in community-dwelling older adults, based on voice recordings obtained from the picture description task (PDT). Methods: We recruited 127 participants aged 50 years and older and collected clinical information through a short form of the Comprehensive Geriatric Assessment scale. Voice recordings were collected with a tablet device during the Korean version of the PDT, and we preprocessed audio data to remove background noise before feature extraction. Three artificial intelligence (AI) models were developed for identifying frailty status: SpeechAI (using speech data only), DemoAI (using demographic data only), and DemoSpeechAI (combining both data types). Results: Our models were trained and evaluated on the basis of 5-fold cross-validation for 127 participants and compared. The SpeechAI model, using deep learning–based acoustic features, outperformed in terms of accuracy and area under the receiver operating characteristic curve (AUC), 80.4% (95% CI 76.89%‐83.91%) and 0.89 (95% CI 0.86‐0.92), respectively, while the model using only demographics showed an accuracy of 67.96% (95% CI 67.63%‐68.29%) and an AUC of 0.74 (95% CI 0.73‐0.75). The SpeechAI model outperformed the model using only demographics significantly in AUC (t4=8.705 [2-sided]; P<.001). The DemoSpeechAI model, which combined demographics with deep learning–based acoustic features, showed superior performance (accuracy 85.6%, 95% CI 80.03%‐91.17% and AUC 0.93, 95% CI 0.89‐0.97), but there was no significant difference in AUC between the SpeechAI and DemoSpeechAI models (t4=1.057 [2-sided]; P=.35). Compared with models using traditional acoustic features from the openSMILE toolkit, the SpeechAI model demonstrated superior performance (AUC 0.89) over traditional methods (logistic regression: AUC 0.62; decision tree: AUC 0.57; random forest: AUC 0.66). Conclusions: Our findings demonstrate that vocal biomarkers derived from deep learning–based acoustic features can be effectively used to predict frailty status in community-dwelling older adults. The SpeechAI model showed promising accuracy and AUC, outperforming models based solely on demographic data or traditional acoustic features. Furthermore, while the combined DemoSpeechAI model showed slightly improved performance over the SpeechAI model, the difference was not statistically significant. These results suggest that speech-based AI models offer a noninvasive, scalable method for frailty detection, potentially streamlining assessments in clinical and community settings.
- 16 January 2025
- Published by JMIR Publications Inc. in JMIR Medical Informatics
- Vol. 13, e57298
Open AccessDevelopment and Validation of a Machine Learning Method Using Vocal Biomarkers for Identifying Frailty in Community-Dwelling Older Adults: Cross-Sectional Study
Background: The two most commonly used methods to identify frailty are the frailty phenotype and the frailty index. However, both methods have limitations in clinical application. In addition, methods for measuring frailty have not yet been standardized. Objective: We aimed to develop and validate a classification model for predicting frailty status using vocal biomarkers in community-dwelling older adults, based on voice recordings obtained from the picture description task (PDT). Methods: We recruited 127 participants aged 50 years and older and collected clinical information through a short form of the Comprehensive Geriatric Assessment scale. Voice recordings were collected with a tablet device during the Korean version of the PDT, and we preprocessed audio data to remove background noise before feature extraction. Three artificial intelligence (AI) models were developed for identifying frailty status: SpeechAI (using speech data only), DemoAI (using demographic data only), and DemoSpeechAI (combining both data types). Results: Our models were trained and evaluated on the basis of 5-fold cross-validation for 127 participants and compared. The SpeechAI model, using deep learning–based acoustic features, outperformed in terms of accuracy and area under the receiver operating characteristic curve (AUC), 80.4% (95% CI 76.89%‐83.91%) and 0.89 (95% CI 0.86‐0.92), respectively, while the model using only demographics showed an accuracy of 67.96% (95% CI 67.63%‐68.29%) and an AUC of 0.74 (95% CI 0.73‐0.75). The SpeechAI model outperformed the model using only demographics significantly in AUC (t4=8.705 [2-sided]; P<.001). The DemoSpeechAI model, which combined demographics with deep learning–based acoustic features, showed superior performance (accuracy 85.6%, 95% CI 80.03%‐91.17% and AUC 0.93, 95% CI 0.89‐0.97), but there was no significant difference in AUC between the SpeechAI and DemoSpeechAI models (t4=1.057 [2-sided]; P=.35). Compared with models using traditional acoustic features from the openSMILE toolkit, the SpeechAI model demonstrated superior performance (AUC 0.89) over traditional methods (logistic regression: AUC 0.62; decision tree: AUC 0.57; random forest: AUC 0.66). Conclusions: Our findings demonstrate that vocal biomarkers derived from deep learning–based acoustic features can be effectively used to predict frailty status in community-dwelling older adults. The SpeechAI model showed promising accuracy and AUC, outperforming models based solely on demographic data or traditional acoustic features. Furthermore, while the combined DemoSpeechAI model showed slightly improved performance over the SpeechAI model, the difference was not statistically significant. These results suggest that speech-based AI models offer a noninvasive, scalable method for frailty detection, potentially streamlining assessments in clinical and community settings.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (12)
Prediction of 5-Year Survival Rate After Hip Fracture Surgery Using a Comprehensive Geriatric Assessment-Based Frailty Score Model
Choi JY, et al. J Korean Med Sci. 2024 Dec;40:e40. https://doi.org/10.3346/jkms.2025.40.e40
- 1 January 2025
- Published by XMLink in Journal of Korean Medical Science
- Vol. 40 (12)
Open AccessPrediction of 5-Year Survival Rate After Hip Fracture Surgery Using a Comprehensive Geriatric Assessment-Based Frailty Score Model
Choi JY, et al. J Korean Med Sci. 2024 Dec;40:e40. https://doi.org/10.3346/jkms.2025.40.e40
- Open Access
- 10 July 2024
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 67 (7) , 461-466
Diagnosis and management of sarcopenia
Background: Sarcopenia refers to the progressive and generalized loss of skeletal muscle mass, strength, and function and is associated with falls, fractures, hospitalization, and even mortality. Owing to rapid population aging, the prevalence of sarcopenia is expected to increase, and this condition is increasingly gaining attention as an important topic in research and clinical settings. This review focuses on the diagnosis, pathophysiology, and management of sarcopenia.Current Concepts: Diagnosis of sarcopenia can be confirmed based on low muscle mass accompanied by low muscle strength, or low physical performance. The European Working Group on Sarcopenia in Older People and the Asian Working Group for Sarcopenia guidelines are commonly used in clinical practice. Intrinsic factors associated with skeletal muscles, such as inflammation, anabolic resistance, mitochondria, and neuromuscular junctions, combined with extrinsic factors associated with the systemic environment, including decreased endocrine function, malnutrition, and immobilization all play a role in impaired muscle anabolism, muscle atrophy, and weakness. Currently, the Food and Drug Administration has not approved any specific medications for treatment of sarcopenia. Therefore, non-pharmacological interventions such as aerobic, resistance, and combined exercise and appropriate nutrition (protein and essential amino acids) are important for prevention and treatment of sarcopenia.Discussion and Conclusion: Sarcopenia is a manageable target for improvement of overall health outcomes. Exercise and nutrition are essential components of nonpharmacological management of sarcopenia. Future studies are needed to identify early diagnostic biomarkers and pharmacologic targets and to develop consistent pre-emptive management strategies and sensitive measures to predict effectiveness of sarcopenia management and treatment response.
- 10 July 2024
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 67 (7) , 461-466
Open AccessDiagnosis and management of sarcopenia
Background: Sarcopenia refers to the progressive and generalized loss of skeletal muscle mass, strength, and function and is associated with falls, fractures, hospitalization, and even mortality. Owing to rapid population aging, the prevalence of sarcopenia is expected to increase, and this condition is increasingly gaining attention as an important topic in research and clinical settings. This review focuses on the diagnosis, pathophysiology, and management of sarcopenia.Current Concepts: Diagnosis of sarcopenia can be confirmed based on low muscle mass accompanied by low muscle strength, or low physical performance. The European Working Group on Sarcopenia in Older People and the Asian Working Group for Sarcopenia guidelines are commonly used in clinical practice. Intrinsic factors associated with skeletal muscles, such as inflammation, anabolic resistance, mitochondria, and neuromuscular junctions, combined with extrinsic factors associated with the systemic environment, including decreased endocrine function, malnutrition, and immobilization all play a role in impaired muscle anabolism, muscle atrophy, and weakness. Currently, the Food and Drug Administration has not approved any specific medications for treatment of sarcopenia. Therefore, non-pharmacological interventions such as aerobic, resistance, and combined exercise and appropriate nutrition (protein and essential amino acids) are important for prevention and treatment of sarcopenia.Discussion and Conclusion: Sarcopenia is a manageable target for improvement of overall health outcomes. Exercise and nutrition are essential components of nonpharmacological management of sarcopenia. Future studies are needed to identify early diagnostic biomarkers and pharmacologic targets and to develop consistent pre-emptive management strategies and sensitive measures to predict effectiveness of sarcopenia management and treatment response.
- 21 March 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (6) , 1383-1390
Association Between Orthostatic Hypertension and Frailty Among Older Patients With Hypertension
BACKGROUND: Frailty frequently coexists with hypertension in older patients. We aimed to evaluate the association between frailty and positional change in blood pressure, especially orthostatic hypertension. METHODS: Participants were recruited from 12 University hospitals in South Korea. Using a digital device, trained research nurses measured blood pressure in the supine and standing positions. Physical frailty was evaluated using the Korean version of the FRAIL questionnaire, gait speed, and handgrip strength. Orthostatic hypertension was defined as a ≥20-mm Hg increase in systolic blood pressure within 3 minutes of standing and upright systolic blood pressure of ≥140 mm Hg. RESULTS: We analyzed the data of 2065 participants who had been enrolled until December 31, 2022. The mean age was 73.2±5.6 years, and 52.0% were female. The mean blood pressure was 137.1±14.9/75.1±9.7 mm Hg. Among the participants, 1886 (91.3%) showed normal response after standing, but 94 (4.6%) had orthostatic hypertension, and 85 (4.1%) had orthostatic hypotension. Orthostatic hypertension was associated with female sex, obesity, cognitive function, physical frailty, and lower quality of life. In the multivariable analysis, body mass index and frailty status were independently associated with orthostatic hypertension. CONCLUSIONS: Orthostatic hypertension is associated with physical frailty, cognitive impairment, and low quality of life in older patients with hypertension. Therefore, evaluation of orthostatic blood pressure changes to confirm orthostatic hypertension or hypotension in frail older adults will serve as an important diagnostic procedure in vulnerable patients. Further studies are required to identify the underlying mechanisms of this association.
- 21 March 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (6) , 1383-1390
Association Between Orthostatic Hypertension and Frailty Among Older Patients With Hypertension
BACKGROUND: Frailty frequently coexists with hypertension in older patients. We aimed to evaluate the association between frailty and positional change in blood pressure, especially orthostatic hypertension. METHODS: Participants were recruited from 12 University hospitals in South Korea. Using a digital device, trained research nurses measured blood pressure in the supine and standing positions. Physical frailty was evaluated using the Korean version of the FRAIL questionnaire, gait speed, and handgrip strength. Orthostatic hypertension was defined as a ≥20-mm Hg increase in systolic blood pressure within 3 minutes of standing and upright systolic blood pressure of ≥140 mm Hg. RESULTS: We analyzed the data of 2065 participants who had been enrolled until December 31, 2022. The mean age was 73.2±5.6 years, and 52.0% were female. The mean blood pressure was 137.1±14.9/75.1±9.7 mm Hg. Among the participants, 1886 (91.3%) showed normal response after standing, but 94 (4.6%) had orthostatic hypertension, and 85 (4.1%) had orthostatic hypotension. Orthostatic hypertension was associated with female sex, obesity, cognitive function, physical frailty, and lower quality of life. In the multivariable analysis, body mass index and frailty status were independently associated with orthostatic hypertension. CONCLUSIONS: Orthostatic hypertension is associated with physical frailty, cognitive impairment, and low quality of life in older patients with hypertension. Therefore, evaluation of orthostatic blood pressure changes to confirm orthostatic hypertension or hypotension in frail older adults will serve as an important diagnostic procedure in vulnerable patients. Further studies are required to identify the underlying mechanisms of this association.
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (10) , e84
Characteristics According to Frailty Status Among Older Korean Patients With Hypertension
Choi JY, et al. J Korean Med Sci. 2024 Feb;39(10):e84. https://doi.org/10.3346/jkms.2024.39.e84
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (10) , e84
Open AccessCharacteristics According to Frailty Status Among Older Korean Patients With Hypertension
Choi JY, et al. J Korean Med Sci. 2024 Feb;39(10):e84. https://doi.org/10.3346/jkms.2024.39.e84